Beranda › Gagal Jantung › Virginia › Arlington
Uji klinis Gagal Jantung di Arlington, VA
15 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ELEVATE-HFpEF Clinical Study
Menerima peserta
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Menerima pesertaFase 3
- Research Site, Falls Church · 4 mi jauhnya
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Menerima pesertaFase 3
- Carient Heart and Vascular, Manassas · 22 mi jauhnya
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Menerima pesertaFase 3
- Carient Heart and Vascular, Manassas · 22 mi jauhnya
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Menerima pesertaFase 2
- Inova Heart and Vascular Institute, Falls Church · 4 mi jauhnya
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Menerima pesertaFase 3
- Research Site, Arlington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Menerima pesertaFase 3
- Conquest Research, LLC, Arlington
- Virginia Heart, Falls Church · 4 mi jauhnya
- Carient Heart and Vascular, Manassas · 22 mi jauhnya
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Menerima pesertaFase 3
- Research Site, Falls Church · 4 mi jauhnya
- Research Site, Burke · 11 mi jauhnya
- Research Site, Potomac · 11 mi jauhnya
- dan 2 lainnya
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Menerima peserta
- Inova Fairfax Medical Campus, Falls Church · 4 mi jauhnya
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Menerima pesertaStudi observasional
- Falls Church, Falls Church · 4 mi jauhnya
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Menerima pesertaFase 3
- Conquest Research, Vienna · 9 mi jauhnya
- Carient Heart and Vascular, Manassas · 22 mi jauhnya
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
Menerima peserta
- Inova Health System, Falls Church · 4 mi jauhnya
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Menerima peserta
- Inova Fairfax Medical Campus, Falls Church · 4 mi jauhnya
Left vs Left Randomized Clinical Trial
Menerima peserta
- Inova Heart and Vascular Institute, Falls Church · 4 mi jauhnya
Cardiogenic Shock Working Group Registry
Menerima pesertaStudi observasional
- Inova Health System, Falls Church · 4 mi jauhnya
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker (semua jenis)48 studi
- Kanker Payudara46 studi
- Kanker Ovarium46 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Karsinoma Sel Skuamosa Kepala dan Leher26 studi
- Kanker Paru Sel Kecil23 studi
- Kanker Payudara Triple-Negatif20 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.